<DOC>
	<DOCNO>NCT01143181</DOCNO>
	<brief_summary>CMX001 orally administer lipid conjugate synthetic nucleotide analog cidofovir ( CDV ) . The conjugate believe absorbed small intestine deliver target organ throughout body cross cell membrane facilitate passive diffusion . Inside cell , CMX001 cleave intracellular phospholipases release CDV convert active antiviral agent , CDV-diphosphate ( CDV-PP ) , intracellular anabolic kinase . Adults adolescent , regardless viral infection/disease , maximum weekly dose 200 mg i.e. , 200 mg weekly OR 100 mg twice weekly ; exceed 4mg/kg total weekly dose . Pediatric subject ( &lt; 12 year ) , regardless viral infection/disease , maximum weekly dose 4 mg/kg i.e. , 4 mg/kg weekly OR 2 mg/kg twice weekly .</brief_summary>
	<brief_title>A Multicenter , Open-label Study CMX001 Treatment Serious Diseases Conditions Caused dsDNA Viruses</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Monkeypox</mesh_term>
	<criteria>1 . Patients immediately lifethreatening serious disease condition cause CMV , ADV , HSV , VAVC , VARV monkeypox virus ( ) . 2 . Life expectancy least 2 week commitment continuation supportive care least 4 week . 3 . Able ingest absorb oral medication ( judgment investigator base lack significant GI pathology small bowel resection ileus ) . [ Note : Use TPN ( total parenteral nutrition ) exclusionary long reason use would disqualify patient base criterion . ] 4 . Willing able understand provide write informed consent . For minor incapable provide write informed consent ( i.e. , incapacitate ) , understood , write informed consent must provide parent legal guardian representative . 5 . To best ( parent/guardian ) knowledge , willing able participate require study activity duration study . 6 . In judgment investigator , patient comparable satisfactory therapeutic alternative available 1 . Females pregnant currently nurse . 2 . Patients hypersensitivity cidofovir CMX001 . 3 . Patients whose longterm prognosis include poor likelihood survival due irreversible organ failure include , example , patient frank hepatic failure adult Grade 4 GVHD GI tract . 4 . Patients eligible enrollment able participate clinical trial evaluate CMX001 . 5 . Patients condition would , judgment investigator , put patient increase risk participation study , interfere conduct study .</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>CMV , ADV , HSV , VAVC , VARV</keyword>
	<keyword>life threaten</keyword>
</DOC>